Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds

Biomaterials

Volumn 32, Issue 1, 2011, Pages 279-287

  Teo, Erin Yiling ^a   Ong, Shin Yeu ^b   Khoon Chong, Mark Seow ^c   Zhang, Zhiyong ^a   Lu, Jia ^b   Moochhala, Shabbir ^b   Ho, Bow ^a   Teoh, Swee Hin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibiotic delivery system; Fused deposition modeling; Infection control; Polycaprolactone tricalcium phosphate

Indexed keywords

3-DIMENSIONAL; ANTIBACTERIAL AGENT; AREA REDUCTION; COLLAGEN DEPOSITION; DELIVERY SYSTEMS; ELUTION PROFILES; FUSED DEPOSITION MODELING; GENTAMICIN SULPHATES; IN-VITRO; INFECTED WOUNDS; INFECTION CONTROL; MATRIX; MICE MODELS; MICRO ARCHITECTURES; SOLVENT-FREE METHOD; TARGETED DELIVERY; TISSUE ADHESION; TREATMENT GROUP; TRI-CALCIUM PHOSPHATES; VARYING LOAD; WOUND HEALING;

ANTIBIOTICS; BACTERIOLOGY; BIOLOGICAL MATERIALS; BIOMATERIALS; TRANSMISSION CONTROL PROTOCOL;

POLYCAPROLACTONE;

ANTIBIOTIC AGENT; CALCIUM PHOSPHATE; GENTAMICIN; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HISTOLOGY; INFECTION CONTROL; INFLAMMATION; LEUKOCYTE COUNT; MODEL; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURGICAL TAPE; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; CELL DEATH; COLONY COUNT, MICROBIAL; DRUG DELIVERY SYSTEMS; GENTAMICINS; LEUKOCYTE COUNT; MICE; MICROBIAL SENSITIVITY TESTS; POLYESTERS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TISSUE SCAFFOLDS; WOUND HEALING; WOUND INFECTION;

MUS;

EID: 78349308872     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.089     Document Type: Article

References (45)

1. Ragel C.V., Vallet-Regi M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000 Sep 5, 51(3):424-429.
2. Coello R., Charlett A., Wilson J., Ward V., Pearson A., Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005 Jun, 60(2):93-103.
3. Tunney M.M., Patrick S., Gorman S.P., Nixon J.R., Anderson N., Davis R.I., et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 1998 Jul, 80(4):568-572.
4. Dreghorn C.R., Hamblen D.L. Revision arthroplasty: a high price to pay. BMJ 1989 Mar 11, 298(6674):648-649.
5. Aronson N.E., Sanders J.W., Moran K.A. In harm's way: infections in deployed American military forces. Clin Infect Dis 2006 Oct 15, 43(8):1045-1051.
6. Murray C.K., Roop S.A., Hospenthal D.R., Dooley D.P., Wenner K., Hammock J., et al. Bacteriology of war wounds at the time of injury. Mil Med 2006 Sep, 171(9):826-829.
7. Selkon J.B. The bacteriology of war wounds. J R Nav Med Serv 1981, 67(3):160-164.
8. Cornell C.N., Tyndall D., Waller S., Lane J.M., Brause B.D. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J Orthop Res 1993 Sep, 11(5):619-626.
9. Shinto Y., Uchida A., Korkusuz F., Araki N., Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 1992 Jul, 74(4):600-604.
10. Garvin K., Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res 2005 Aug, 437:105-110.
11. Lazzarini L., Mader J.T., Calhoun J.H. Osteomyelitis in long bones. J Bone Joint Surg Am 2004 Oct, 86-A(10):2305-2318.
12. Changez M., Koul V., Krishna B., Dinda A.K., Choudhary V. Studies on biodegradation and release of gentamicin sulphate from interpenetrating network hydrogels based on poly(acrylic acid) and gelatin: in vitro and in vivo. Biomaterials 2004 Jan, 25(1):139-146.
13. Chang H.I., Perrie Y., Coombes A.G. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone. J Control Release 2006 Jan 10, 110(2):414-421.
14. Pitt C.G., Jeffcoat A.R., Zweidinger R.A., Schindler A. Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(dl-lactic acid), and their copolymers. J Biomed Mater Res 1979 May, 13(3):497-507.
15. Benoit M.A., Baras B., Gillard J. Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999 Jul 5, 184(1):73-84.
16. Rai B., Teoh S.H., Ho K.H. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. J Control Release 2005 Oct 3, 107(2):330-342.
17. Rai B., Teoh S.H., Hutmacher D.W., Cao T., Ho K.H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005 Jun, 26(17):3739-3748.
18. Shiozuka M., Wagatsuma A., Kawamoto T., Sasaki H., Shimada K., Takahashi Y., et al. Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders. J Biochem 2009 Nov 11.
19. Griffis C.D., Metcalfe S., Bowling F.L., Boulton A.J., Armstrong D.G. The use of gentamycin-impregnated foam in the management of diabetic foot infections: a promising delivery system?. Expert Opin Drug Deliv 2009 Jun, 6(6):639-642.
20. Aviv M., Berdicevsky I., Zilberman M. Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J Biomed Mater Res A 2007 Oct, 83(1):10-19.
21. Fraser J.F., Bodman J., Sturgess R., Faoagali J., Kimble R.M. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 2004 Feb, 30(1):35-41.
22. Ip M., Lui S.L., Poon V.K., Lung I., Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006 Jan, 55(Pt 1):59-63.
23. Marques A.P., Reis R.L., Hunt J.A. The biocompatibility of novel starch-based polymers and composites: in vitro studies. Biomaterials 2002 Mar, 23(6):1471-1478.
24. Burd A., Kwok C.H., Hung S.C., Chan H.S., Gu H., Lam W.K., et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 2007 Jan-Feb, 15(1):94-104.
25. Mi F.L., Wu Y.B., Shyu S.S., Schoung J.Y., Huang Y.B., Tsai Y.H., et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002 Mar 5, 59(3):438-449.
26. Gopinath D., Kumar M.S., Selvaraj D., Jayakumar R. Pexiganan-incorporated collagen matrices for infected wound-healing processes in rat. J Biomed Mater Res A 2005 Jun 1, 73(3):320-331.
27. Kirker K.R., Luo Y., Nielson J.H., Shelby J., Prestwich G.D. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 2002 Sep, 23(17):3661-3671.
28. Noorjahan S.E., Sastry T.P. An in vivo study of hydrogels based on physiologically clotted fibrin-gelatin composites as wound-dressing materials. J Biomed Mater Res B Appl Biomater 2004 Nov 15, 71(2):305-312.
29. Martineau L., Shek P.N. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties. Burns 2006 Mar, 32(2):172-179.
30. Miyai T., Ito A., Tamazawa G., Matsuno T., Sogo Y., Nakamura C., et al. Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis. Biomaterials 2008 Jan, 29(3):350-358.
31. Kim T.G., Lee D.S., Park T.G. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide). Int J Pharm 2007 Jun 29, 338(1-2):276-283.
32. van de Belt H., Neut D., van Horn J.R., van der Mei H.C., Schenk W. Busscher HJ. or not to treat?. Nat Med 1999 Apr, 5(4):358-359.
33. Stallmann H., Faber C., Bronckers A., Nieuw Amerongen A., Wuisman P. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculoskelet Disord 2006, 7(1):18.
34. Haas A.F. Wound healing. Dermatol Nurs 1995 Feb, 7(1):28-34. 74.
35. Strodtbeck F. Physiology of wound healing. Newborn Infant Nurs Rev 2001, 1(1):43-52.
36. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999 Jun, 37(6):1771-1776.
37. Dow G., Browne A., Sibbald R.G. Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy Wound Manage 1999 Aug, 45(8):23-27. 29-40; quiz 41-22.
38. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage 2003 Jul, 49(7A Suppl):1-7.
39. Edwards R., Harding K.G. Bacteria and wound healing. Curr Opin Infect Dis 2004 Apr, 17(2):91-96.
40. Moulin V., Auger F.A., Garrel D., Germain L. Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns 2000 Feb, 26(1):3-12.
41. Ong S.Y., Wu J., Moochhala S.M., Tan M.H., Lu J. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008 Nov, 29(32):4323-4332.
42. Robson M., Kucukcelebi A., Carp S.S., Hayward P.G., Hui P.S., Cowan W.T., et al. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur J Clin Microbiol Infect Dis 1994, 13(Suppl. 2):S41-S46.
43. Steiling H., Munz B., Werner S., Brauchle M. Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Exp Cell Res 1999 Mar 15, 247(2):484-494.
44. Shapiro N.I., Wolfe R.E., Wright S.B., Moore R., Bates D.W. Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med 2008 Oct, 35(3):255-264.
45. Wound-healing physiology 1991, Mosby, St Louis, MO. 2nd ed. J. Waldrop, D. Doughty (Eds.).